vial with a syringe in this photo illustration, taken in Brussels, Belgium, on December 3, 2023. Weight-loss treatments like semaglutide and tirzepatide have been game-changers for many individuals seeking to manage their weight. However, shortages and high costs have created significant barriers, prompting some patients to turn to compounded versions of these medications.
The FDA allows the compounding of patented drugs like Ozempic and Mounjaro only when there’s an official shortage, as is currently the case with semaglutide and tirzepatide. Despite this,While the FDA can authorize a drug for compounding, it does not oversee the production process or test the final product for safety and efficacy.when the approved version is available.
This lack of oversight and potential use of unapproved ingredients can lead to serious consequences, including contamination or incorrect dosages. The FDA has warned that some compounding pharmacies use unapproved starting ingredients, leading to potential adverse events.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BestLifeOnline - 🏆 533. / 51 Read more »
Source: wfaa - 🏆 543. / 51 Read more »